Federal Rescheduling Developments (Schedule III Updates)
The federal classification of cannabis dictates the financial reality of the entire industry. The December 18, 2025, Executive Order directing the Department of Justice to expedite the rescheduling of cannabis to Schedule III represents the most significant federal policy shift since the passage of the Controlled Substances Act.
Moving cannabis from Schedule I to Schedule III directly impacts corporate tax liability. Under Schedule I, Internal Revenue Code (IRC) Section 280E prohibits operators from deducting ordinary business expenses, limiting deductions strictly to the Cost of Goods Sold (COGS). A finalized Schedule III designation removes the 280E burden, allowing dispensaries and cultivators to deduct payroll, rent, and marketing expenses under IRC Section 162.
However, operators must track the implementation timeline closely. The Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) must finalize the administrative rulemaking process before the tax relief takes effect. Furthermore, Schedule III status triggers new compliance obligations regarding FDA oversight and Department of Transportation (DOT) drug testing mandates for commercial drivers transporting cannabis products.
State Market Expansions
State legislatures continue to refine their licensing frameworks, transitioning from limited medical programs to expansive adult-use markets. These expansions frequently introduce new license categories, social equity provisions, and revised municipal zoning requirements.
- Limited-License Market Adjustments: States like Illinois and New York operate under strict license caps. Regulatory updates in these jurisdictions often involve the release of new dispensary or cultivation licenses through highly competitive, merit-based application windows. Operators must monitor the Department of Financial and Professional Regulation (IDFPR) and the Office of Cannabis Management (OCM) for application scoring rubrics and capitalization requirements.
- Dual-Licensing Hurdles: In mature markets like California, the Department of Cannabis Control (DCC) frequently updates its regulations regarding local authorization. Operators must track changes to the California Environmental Quality Act (CEQA) compliance standards and municipal conditional use permit requirements, as state licenses remain contingent upon local approval.
- Interstate Commerce Triggers: Several states, including Oregon and Washington, have passed legislation authorizing the interstate transfer of cannabis products, contingent upon federal policy changes or specific Department of Justice memorandums. Tracking these statutory triggers is critical for multi-state operators (MSOs) planning regional supply chain integrations.
Recent Compliance Enforcement Actions
State regulatory agencies are escalating their enforcement actions, shifting from educational warnings to punitive fines and license revocations. Analyzing recent enforcement trends provides operators with a roadmap for internal compliance audits.
- METRC Track-and-Trace Violations: Inventory discrepancies remain the leading cause of regulatory fines. Agencies are aggressively penalizing operators for failing to log plant tags, misreporting harvest weights, and executing unauthorized product transfers outside the METRC system.
- Security and Surveillance Failures: State inspectors routinely audit facility security systems. Recent enforcement actions highlight penalties for failing to maintain 90-day video retention logs, operating with blind spots in vault areas, and neglecting visitor log sign-in protocols.
- Packaging and Labeling Infractions: The marketing of cannabis products is heavily scrutinized to prevent appeal to minors. Regulators frequently issue product recalls and fines for non-compliant packaging, missing universal symbols, and inaccurate THC potency labeling.